Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study
Psychiatry and Clinical Psychopharmacology · 16.06.2025 · 36 (3) · 285-292
DOI: 10.5152/pcp.2026.261269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry and Clinical Psychopharmacology, online erschienen am 16.06.2025. Verfasst von Jingyi Tong. Beteiligte Einrichtung: Department of Psychiatry, Sichuan Taikang Hospital, Chengdu, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Psychiatry, Sichuan Taikang Hospital, Chengdu, China.
ORCID-Profile: Jingyi Tong
Zitieren
APA
Tong, J. (2025). Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study. Psychiatry and Clinical Psychopharmacology, 36(3), 285-292. https://doi.org/10.5152/pcp.2026.261269
Vancouver
Tong J. Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study. Psychiatry and Clinical Psychopharmacology. 2025;36(3):285-292. doi:10.5152/pcp.2026.261269
BibTeX
@article{Tong2025,
author = {Tong, Jingyi},
title = {Lamotrigine as a Potential Therapeutic Agent for Psychosomatic Disorders: Insights from a Drug Target–Based Mendelian Randomization Study},
journal = {Psychiatry and Clinical Psychopharmacology},
year = {2025},
volume = {36},
number = {3},
pages = {285--292},
doi = {10.5152/pcp.2026.261269}
}
EUVIMED